ScholarIQanswers from OpenAlex
UCSF Helen Diller Family Comprehensive Cancer Center
InstitutionResearch output, impact & collaborations
UCSF Helen Diller Family Comprehensive Cancer Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQrecord summary
UCSF Helen Diller Family Comprehensive Cancer Center is a research organisation in San Francisco, US. OpenAlex records 10,480 works and 2,070,619 citations for it. 1,472 researchers list it as their most recent affiliation.
How many works does UCSF Helen Diller Family Comprehensive Cancer Center have?
ScholarIQindexed works
UCSF Helen Diller Family Comprehensive Cancer Center has 10,480 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does UCSF Helen Diller Family Comprehensive Cancer Center have?
ScholarIQcitation count
UCSF Helen Diller Family Comprehensive Cancer Center has 2,070,619 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQresearcher count
UCSF Helen Diller Family Comprehensive Cancer Center has 1,472 researchers in the ScholarIQ index.
What is the average h-index at UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQavg h-index
UCSF Helen Diller Family Comprehensive Cancer Center has an average h-index of 64.5 in OpenAlex.
What is the ROR of UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQror
The ROR for UCSF Helen Diller Family Comprehensive Cancer Center is on the source record.
What is the OpenAlex record for UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQopenalex
The OpenAlex for UCSF Helen Diller Family Comprehensive Cancer Center is on the source record.
Who are the most-cited researchers behind UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQtop researchers by citations
What are the most-cited papers on UCSF Helen Diller Family Comprehensive Cancer Center?
ScholarIQmost cited works
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes
Non–Small Cell Lung Cancer, Version 4.2024
Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aditya Juloori, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Jonathan W. Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Lisa Hang
How much of the research on UCSF Helen Diller Family Comprehensive Cancer Center is open access?
ScholarIQopen access share
63%OPEN ACCESS